Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT06858839 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

3853

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Maridebart Cafraglutide
DRUG: Placebo

Sponsor

Amgen